Piramal Pharma Solutions New API Plant in Canada Goes Online; Initial Production Runs Successfully Completed

    © 2024 Piramal Enterprises Ltd.

    Piramal Pharma Solutions Announces Winner of its Winter 2022 Award for Excellence in Patient Centricity

    Piramal Pharma Solutions Strengthens North American Capabilities with Addition of Development/Commercial Scale Roller Compactor at Sellersville, PA Site

    Piramal Pharma Solutions Expands In Vitro Biology Capabilities at Ahmedabad Discovery Services Site

    Piramal Pharma Ltd. To Invest Minority Stake in Yapan Bio, India-Based CDMO Providing Expertise in Biologics and Vaccines

    Piramal Pharma Solutions Announces Winner of its Inaugural Award for Excellence in Patient Centricity

    Piramal Pharma Solutions Enters Into a Master Services Agreement with Plus Therapeutics, Inc.

    Piramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc. for TH1902 Peptide-Drug Conjugate

    Piramal Pharma Solutions Invests ~$32 Million to Expand its Riverview Michigan Facility for Additional Capacity in Potent and Non-Potent API Development and Manufacturing

    Piramal Pharma Solutions to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs